Robin T Zon1, Erin B Kennedy2, Kerin Adelson3, Sibel Blau4, Natalie Dickson5, David Gill6, Nicole Laferriere7, Ana Maria Lopez8, Therese M Mulvey9, Debra Patt10, Todd A Pickard11, Terry Purdom12, Trevor J Royce13,14, Ashley L Sumrall15, Ray D Page16. 1. Michiana Hematology Oncology, Mishawaka, IN. 2. American Society of Clinical Oncology, Alexandria, VA. 3. Smilow Cancer Hospital, Yale School of Medicine, Guilford, CT. 4. Northwest Medical Specialties, Seattle, WA. 5. Tennessee Oncology, Nashville, TN. 6. Intermountain Healthcare, Salt Lake City, UT. 7. North West Regional Cancer Center and Northern Ontario School of Medicine, Thunder Bay, Ontario, Canada. 8. Jefferson Health New Jersey, Sidney Kimmel Cancer Center, Sewell, NJ. 9. Massachusetts General Hospital, Boston, MA. 10. Texas Oncology, Austin, TX. 11. University of Texas MD Anderson Cancer Center, Houston, TX. 12. Elevated Hope, Weatherford, TX. 13. Lineberger Comprehensive Cancer Center, Chapel Hill, NC. 14. Flatiron Health, New York, NY. 15. Levine Cancer Institute, Charlotte, NC. 16. The Center for Cancer and Blood Disorders, Fort Worth, TX.
Abstract
PURPOSE: To provide standards and practice recommendations specific to telehealth in oncology. METHODS: A systematic review of the literature on telehealth in oncology was performed, including the use of technologies and telecommunications systems, and other electronic methods of care delivery and sharing of information with patients. The evidence base was combined with the opinion of the ASCO Telehealth Expert Panel to develop telehealth standards and guidance. Public comments were solicited and considered in preparation of the final manuscript. RESULTS: The Expert Panel determined that general guidance on implementing telehealth across general and specialty settings has been published previously and these resources are endorsed. A systematic search for studies on topics specific to oncology resulted in the inclusion of two clinical practice guidelines, 12 systematic reviews, and six primary studies. STANDARDS AND GUIDANCE: Standards and guidance are provided for which patients in oncology can be seen via telehealth, establishment of the doctor-physician relationship, role of allied health professionals, role of advanced practice providers, multidisciplinary cancer conferences, and teletrials in oncology. Additional information is available at www.asco.org/standards.
PURPOSE: To provide standards and practice recommendations specific to telehealth in oncology. METHODS: A systematic review of the literature on telehealth in oncology was performed, including the use of technologies and telecommunications systems, and other electronic methods of care delivery and sharing of information with patients. The evidence base was combined with the opinion of the ASCO Telehealth Expert Panel to develop telehealth standards and guidance. Public comments were solicited and considered in preparation of the final manuscript. RESULTS: The Expert Panel determined that general guidance on implementing telehealth across general and specialty settings has been published previously and these resources are endorsed. A systematic search for studies on topics specific to oncology resulted in the inclusion of two clinical practice guidelines, 12 systematic reviews, and six primary studies. STANDARDS AND GUIDANCE: Standards and guidance are provided for which patients in oncology can be seen via telehealth, establishment of the doctor-physician relationship, role of allied health professionals, role of advanced practice providers, multidisciplinary cancer conferences, and teletrials in oncology. Additional information is available at www.asco.org/standards.
Authors: Dragomir Svetozarov Stoyanov; Nikolay Vladimirov Conev; Ivan Shterev Donev; Ivan Dimitrov Tonev; Teodorika Vitalinova Panayotova; Eleonora Georgieva Dimitrova-Gospodinova Journal: Support Care Cancer Date: 2022-03-15 Impact factor: 3.603
Authors: Kushal T Kadakia; Celynne A Balatbat; Albert L Siu; I Glenn Cohen; Consuelo H Wilkins; Victor J Dzau; Anaeze C Offodile 2nd Journal: Milbank Q Date: 2022-09-23 Impact factor: 6.237
Authors: Matthew P Smeltzer; Giorgio V Scagliotti; Heather A Wakelee; Tetsuya Mitsudomi; Upal Basu Roy; Russell C Clark; Renee Arndt; Clayton D Pruett; Karen L Kelly; Peter Ujhazy; Melissa L Johnson; Yesim Eralp; Carlos H Barrios; Fabrice Barlesi; Fred R Hirsch; Paul A Bunn Journal: J Thorac Oncol Date: 2022-02-17 Impact factor: 20.121
Authors: Jordan M Alpert; Greenberry Taylor; Chelsea N Hampton; Samantha Paige; Merry Jennifer Markham; Carma L Bylund Journal: JMIR Cancer Date: 2022-02-24
Authors: Michael Jefford; Doris Howell; Qiuping Li; Karolina Lisy; Jane Maher; Catherine M Alfano; Meg Rynderman; Jon Emery Journal: Lancet Date: 2022-04-16 Impact factor: 202.731